First Time Loading...

Crinetics Pharmaceuticals Inc
NASDAQ:CRNX

Watchlist Manager
Crinetics Pharmaceuticals Inc Logo
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Watchlist
Price: 44.71 USD -2.47% Market Closed
Updated: Jun 9, 2024

Crinetics Pharmaceuticals Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Crinetics Pharmaceuticals Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Cash from Operating Activities
-$178.4m
CAGR 3-Years
-37%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Operating Activities
$22.7B
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
15%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Operating Activities
$8.5B
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$8.1B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Operating Activities
$3.9B
CAGR 3-Years
5%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Operating Activities
$4.7B
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
24%

See Also

What is Crinetics Pharmaceuticals Inc's Cash from Operating Activities?
Cash from Operating Activities
-178.4m USD

Based on the financial report for Mar 31, 2024, Crinetics Pharmaceuticals Inc's Cash from Operating Activities amounts to -178.4m USD.

What is Crinetics Pharmaceuticals Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-51%

Over the last year, the Cash from Operating Activities growth was -25%. The average annual Cash from Operating Activities growth rates for Crinetics Pharmaceuticals Inc have been -37% over the past three years , -51% over the past five years .